Search Within

Renier J Brentjens

  1. "MSK Grad Students"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (13)
  3. Review (1)
Groups
  1. Adult Leukemia (28)
  2. Center for Hematologic Malignancies (28)
  3. Department of Medicine (28)
  4. GSK Faculty (28)
  5. Hematologic Malignancies Research (28)
  6. Hematologic Malignancies, Division of (28)

More Groups

People
  1. Craig Sauter (14)
  2. Maria Palomba (14)
  3. Miguel-Angel Perales (14)
  4. Gunjan Shah (13)
  5. Jae Park (13)
  6. Michael Scordo (13)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (12)
  6. 2019 (6)

More Years

Publications
  1. Blood (8)
  2. Blood Advances (3)
  3. Cancer Cell (2)
  4. Cancer Immunology Research (2)
  5. Molecular Therapy (2)
  6. Nature Communications (2)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. Nature Publishing Group (8)
  3. American Association for Cancer Research (2)
  4. Cell Press (2)
  5. Elsevier Inc. (2)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparing gradings of immune effector cells toxicities: Application of ASTCT consensus grading system and implications for clinical management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells
    Meeting Abstract

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J.; Maloy, M. A.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Devlin, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Hematological count recovery in patients undergoing treatment with chimeric antigen receptor T cells (CAR T)
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Maloy, M. A.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Application of CAR T cells for the treatment of solid tumors
    Journal Article

    Khan, J. F.; Khan, A. S.; Brentjens, R. J.
    Progress in Molecular Biology and Translational Science (2019)

    Fulltext@MSK | Save
  • Augmenting CAR T cell mediated anti-tumor efficacy through genetic modification to secrete a novel cytokine IL-36γ
    Meeting Abstract

    Li, X.; Daniyan, A.; Lopez, A.; Purdon, T.; Brentjens, R.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • CD40 ligand-modified chimeric antigen receptor T cells enhance antitumor function by eliciting an endogenous antitumor response
    Journal Article

    Kuhn, N. F.; Purdon, T. J.; van Leeuwen, D. G.; Lopez, A. V.; Curran, K. J.; Daniyan, A. F.; Brentjens, R. J.
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • IL-18 secreting CAR T cells enhance cell persistence, induce prolonged B cell aplasia and eradicate CD19+ tumor cells without need for prior conditioning
    Meeting Abstract

    Avanzi, M. P.; van Leeuwen, D. G.; Li, X.; Cheung, K.; Park, H.; Purdon, T. J.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
    Journal Article

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S. M.; Lubin, M.; Giralt, S.; Goldberg, J. D.; Hanash, A.; Hsu, K.; Jenq, R.; more...
    Blood (2015)

    Fulltext@MSK | Save